WO2006033012A3 - Method of screening for modulators of hepatitis c virus infection - Google Patents
Method of screening for modulators of hepatitis c virus infection Download PDFInfo
- Publication number
- WO2006033012A3 WO2006033012A3 PCT/IB2005/003070 IB2005003070W WO2006033012A3 WO 2006033012 A3 WO2006033012 A3 WO 2006033012A3 IB 2005003070 W IB2005003070 W IB 2005003070W WO 2006033012 A3 WO2006033012 A3 WO 2006033012A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hepatitis
- virus infection
- modulators
- screening
- agent
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0421360A GB0421360D0 (en) | 2004-09-24 | 2004-09-24 | Method |
GB0421360.9 | 2004-09-24 | ||
US62237704P | 2004-10-26 | 2004-10-26 | |
US60/622,377 | 2004-10-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006033012A2 WO2006033012A2 (en) | 2006-03-30 |
WO2006033012A3 true WO2006033012A3 (en) | 2006-08-24 |
Family
ID=36090386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/003070 WO2006033012A2 (en) | 2004-09-24 | 2005-09-19 | Method of screening for modulators of hepatitis c virus infection |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006033012A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009030872A1 (en) * | 2007-09-07 | 2009-03-12 | Mats Axel Atterdag Persson | Materials and methods for the treatment of hepatitis c |
WO2012166459A1 (en) * | 2011-05-27 | 2012-12-06 | Bristol-Myers Squibb Company | Tripeptides incorporating deuterium as inhibitors of hepatitis c virus |
CN105330730A (en) * | 2014-07-29 | 2016-02-17 | 中国科学院上海巴斯德研究所 | Preparation and application of hepatitis C virus recombinant protein |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020160936A1 (en) * | 1999-09-29 | 2002-10-31 | Howard J. Worman | Hcv e2 protein binding agents for treatment of hepatitis c virus infection |
EP1267167A1 (en) * | 2001-06-15 | 2002-12-18 | Pfizer Limited | Method for identifying HCV entry factors |
US20030129746A1 (en) * | 1998-03-27 | 2003-07-10 | Innogenetics N.V. | Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
US6635257B1 (en) * | 1998-06-24 | 2003-10-21 | Innogentics N.V. | Particles of HCV envelope proteins: use for vaccination |
US20040115619A1 (en) * | 2000-12-01 | 2004-06-17 | Darren Schofield | Monoclonal antibodies specific for the e2 glycoprotein of hepatitic c virus and their use in the diagnosis, treatment , and prevention of hepatitis c |
-
2005
- 2005-09-19 WO PCT/IB2005/003070 patent/WO2006033012A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030129746A1 (en) * | 1998-03-27 | 2003-07-10 | Innogenetics N.V. | Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
US6635257B1 (en) * | 1998-06-24 | 2003-10-21 | Innogentics N.V. | Particles of HCV envelope proteins: use for vaccination |
US20020160936A1 (en) * | 1999-09-29 | 2002-10-31 | Howard J. Worman | Hcv e2 protein binding agents for treatment of hepatitis c virus infection |
US20040115619A1 (en) * | 2000-12-01 | 2004-06-17 | Darren Schofield | Monoclonal antibodies specific for the e2 glycoprotein of hepatitic c virus and their use in the diagnosis, treatment , and prevention of hepatitis c |
EP1267167A1 (en) * | 2001-06-15 | 2002-12-18 | Pfizer Limited | Method for identifying HCV entry factors |
Non-Patent Citations (1)
Title |
---|
TAKIKAWA SHINGO ET AL: "Cell fusion activity of hepatitis C virus envelope proteins", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 11, June 2000 (2000-06-01), pages 5066 - 5074, XP002197964, ISSN: 0022-538X * |
Also Published As
Publication number | Publication date |
---|---|
WO2006033012A2 (en) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005012872A3 (en) | Liquid crystal based analyte detection | |
WO2008070727A3 (en) | Recombinant antibodies against hepatitis c virus and methods of obtaining and using same | |
ATE481494T1 (en) | TWO-COMPONENT PLANT EXPRESSION SYSTEM DERIVED FROM RNA VIRUSES | |
NO20016243D0 (en) | Anti-alpha-beta3 recombinant human antibodies, nucleic acids encoding the same, and methods of recycling | |
WO2001057194A3 (en) | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon | |
WO2005087951A3 (en) | Reagents, methods and kits for use in deactivating nucleic acids | |
WO2006093797A3 (en) | Method and kit for detecting porcine reproductive and respiratory syndrome virus | |
WO2005032487A3 (en) | Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus | |
WO2002089731A3 (en) | Agents for treatment of hcv and methods of use | |
WO2010074575A3 (en) | Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. | |
WO2007008071A3 (en) | Method for detecting peptides comprising a cross-beta structure | |
WO2007003324A3 (en) | Cell-free graft consisting of a matrix and a serum | |
WO2005000308A3 (en) | Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c | |
WO2006038129A3 (en) | Hepatitis c virus replication system | |
WO2007064844A3 (en) | Anti-viral griffithsin compounds, compositions, and methods of use | |
WO2006033012A3 (en) | Method of screening for modulators of hepatitis c virus infection | |
WO2003087138A3 (en) | Methods for identifying polypeptide factors interacting with rna | |
WO2004060303A3 (en) | Methods and reagents for the enhancement of virus transduction in the bladder epithelium | |
WO2007053165A3 (en) | Virus protein microarray and uses therefor | |
WO2005000876A3 (en) | Ring finger family proteins and uses related thereto | |
WO2004044182A3 (en) | Highly permissive cell lines for hepatitis c virus replication | |
WO2006002141A3 (en) | Detection of post-translationally modified peptides with liquid crystals | |
WO2002088338A3 (en) | Method for replicating the hepatitis c virus | |
WO2003059943A3 (en) | Conformation-specific, protein kinase binding peptides and related methods and products | |
WO2002100900A3 (en) | Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |